John A. Ward

Array ( [id] => 5521370 [patent_doc_number] => 20090029351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY' [patent_app_type] => utility [patent_app_number] => 12/180822 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4544 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029351.pdf [firstpage_image] =>[orig_patent_app_number] => 12180822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740160 [patent_doc_number] => 08105832 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-01-31 [patent_title] => 'Methods for modifying stem cell characteristics' [patent_app_type] => utility [patent_app_number] => 12/176647 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2944 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105832.pdf [firstpage_image] =>[orig_patent_app_number] => 12176647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7976677 [patent_doc_number] => 08071085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Primary cultured adipocytes for gene therapy' [patent_app_type] => utility [patent_app_number] => 12/175186 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13332 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071085.pdf [firstpage_image] =>[orig_patent_app_number] => 12175186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852001 [patent_doc_number] => 20080317743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission' [patent_app_type] => utility [patent_app_number] => 12/140009 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15184 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317743.pdf [firstpage_image] =>[orig_patent_app_number] => 12140009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367855 [patent_doc_number] => 20090305414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods Of Tissue Engineering' [patent_app_type] => utility [patent_app_number] => 12/136543 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3912 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305414.pdf [firstpage_image] =>[orig_patent_app_number] => 12136543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113398 [patent_doc_number] => 08569573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Method of expanding human hepatocytes in vivo' [patent_app_type] => utility [patent_app_number] => 12/663219 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 51 [patent_no_of_words] => 17558 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710646 [patent_doc_number] => 20080299172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'TISSUE REPAIR IMPLANT' [patent_app_type] => utility [patent_app_number] => 12/132557 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2106 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299172.pdf [firstpage_image] =>[orig_patent_app_number] => 12132557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9971165 [patent_doc_number] => 09018174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Mouse model and treatment of hereditary inclusion body myopathy' [patent_app_type] => utility [patent_app_number] => 12/128517 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 7350 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12128517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296114 [patent_doc_number] => 20090011040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases' [patent_app_type] => utility [patent_app_number] => 12/150986 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17387 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011040.pdf [firstpage_image] =>[orig_patent_app_number] => 12150986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675685 [patent_doc_number] => 20080213314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'COMBINED DNA VACCINE AND BIOLOGICAL MODIFIERS FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/105831 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10031 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213314.pdf [firstpage_image] =>[orig_patent_app_number] => 12105831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102777 [patent_doc_number] => 07728189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression' [patent_app_type] => utility [patent_app_number] => 12/080907 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 8007 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728189.pdf [firstpage_image] =>[orig_patent_app_number] => 12080907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663633 [patent_doc_number] => 20080254540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'METHODS OF GENETICALLY ENCODING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS USING ORTHOGONAL tRNA/SYNTHETASE PAIRS' [patent_app_type] => utility [patent_app_number] => 12/098395 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26656 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254540.pdf [firstpage_image] =>[orig_patent_app_number] => 12098395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446922 [patent_doc_number] => 20090048148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR THERAPEUTIC USE' [patent_app_type] => utility [patent_app_number] => 12/058447 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6489 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048148.pdf [firstpage_image] =>[orig_patent_app_number] => 12058447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697831 [patent_doc_number] => 20080220015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'METHOD OF MODULATING NEUTRALIZING ANTIBODIES FORMATION IN MAMMALS, AND USES THEREOF IN GENE THERAPY, ANIMAL TRANGENESIS AND IN FUNCTIONAL INACTIVATION OF ENDOGENOUS PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/045226 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12406 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220015.pdf [firstpage_image] =>[orig_patent_app_number] => 12045226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509086 [patent_doc_number] => 20090082293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY IN VIVO GENE DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/045658 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33945 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082293.pdf [firstpage_image] =>[orig_patent_app_number] => 12045658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921220 [patent_doc_number] => 08487157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Transgenic rodents having NGF beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins' [patent_app_type] => utility [patent_app_number] => 12/812731 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 9177 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12812731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6191425 [patent_doc_number] => 20110173709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'ECTOPIC, ORTHOTOPIC MODEL FOR REVASCULARIZATION AND TUMOR ASSESSMENT' [patent_app_type] => utility [patent_app_number] => 12/529339 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5571 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20110173709.pdf [firstpage_image] =>[orig_patent_app_number] => 12529339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609373 [patent_doc_number] => 07994146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Method of enhancing an immune response' [patent_app_type] => utility [patent_app_number] => 12/029080 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 55 [patent_no_of_words] => 29610 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994146.pdf [firstpage_image] =>[orig_patent_app_number] => 12029080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859074 [patent_doc_number] => 20080267924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY' [patent_app_type] => utility [patent_app_number] => 12/027375 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38905 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267924.pdf [firstpage_image] =>[orig_patent_app_number] => 12027375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337320 [patent_doc_number] => 20090053784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'EXPRESSION OF AN ACTIVE CARRIER FROM XYLOSE IN GENETICALLY MODIFIED SACCHAROMYCES CEREVISAE' [patent_app_type] => utility [patent_app_number] => 12/025625 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4281 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053784.pdf [firstpage_image] =>[orig_patent_app_number] => 12025625 [rel_patent_id] =>[rel_patent_doc_number] =>)